More than 250 million people worldwide are currently infected with hepatitis B, despite the effectiveness of vaccination and other preventive measures. In terms of treatment, new therapeutic approaches are rapidly developing, promising to achieve the elimination of infected cells and the complete cure of infection. The on-treatment monitoring of these innovative antiviral treatments will require the implementation of new virological tools. Therefore, new biomarkers are being evaluated besides the traditional virological and serological assays in order to obtain information on different steps of the viral replication cycle and to monitor response to therapy more accurately. The purpose of this work is to describe both standard and innovative tools for chronic hepatitis B treatment monitoring, and to analyse their potential and feasibility.

Virological Treatment Monitoring for Chronic Hepatitis B / Loggi, Elisabetta; Gitto, Stefano; Gabrielli, Filippo; Franchi, Elena; Seferi, Hajrie; Cursaro, Carmela; Andreone, Pietro. - In: VIRUSES. - ISSN 1999-4915. - ELETTRONICO. - 14:(2022), pp. 0-0. [10.3390/v14071376]

Virological Treatment Monitoring for Chronic Hepatitis B

Gitto, Stefano;
2022

Abstract

More than 250 million people worldwide are currently infected with hepatitis B, despite the effectiveness of vaccination and other preventive measures. In terms of treatment, new therapeutic approaches are rapidly developing, promising to achieve the elimination of infected cells and the complete cure of infection. The on-treatment monitoring of these innovative antiviral treatments will require the implementation of new virological tools. Therefore, new biomarkers are being evaluated besides the traditional virological and serological assays in order to obtain information on different steps of the viral replication cycle and to monitor response to therapy more accurately. The purpose of this work is to describe both standard and innovative tools for chronic hepatitis B treatment monitoring, and to analyse their potential and feasibility.
2022
14
0
0
Loggi, Elisabetta; Gitto, Stefano; Gabrielli, Filippo; Franchi, Elena; Seferi, Hajrie; Cursaro, Carmela; Andreone, Pietro
File in questo prodotto:
File Dimensione Formato  
viruses-14-01376-v2.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 303.69 kB
Formato Adobe PDF
303.69 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1286594
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact